Methodology

As the demand for in vitro fertilization (IVF) in the United States continues to grow among individuals of all ages, high quality care provided by fertility clinics is of the utmost importance. In the United States, 2% of all infants born every year are conceived using assisted reproductive technology (ART), thus information in the form of success rates abounds for patients seeking treatment. However, the assessment and recommendations of medical experts on the quality of the services provided in combination with objective metrics are sparse.

• To close this gap and provide individuals with a comprehensive resource for informed decision making, Statista and Newsweek have partnered to identify the top 100 fertility clinics in the US.

• Only facilities defined as a fertility clinic and ART Provider by the CDC (Centers for Disease Control and Prevention) were considered in the scope of this project

• The list is based on three data sources:

• Nationwide online survey: Healthcare personnel working in and referring to fertility clinics were asked to recommend the leading fertility clinics in the US
• KPI ART metrics with a focus on indicators relevant to fertility clinics published by CDC
• Accreditations

• During the survey period from November to December 2022, Newsweek and Statista invited over 3,000 reproductive endocrinologists, infertility specialists, obstetricians/gynecologists working in and referring patients to fertility clinics, other medical professionals (e.g., registered nurse, laboratory assistant) and fertility clinic administrators/managers working in fertility clinics to participate in the survey.

• Participants were also asked to assess confidence in their assessment of the fertility clinics, which was used to determine individual weights for the recommendations.

For further information on the methodology please click here.

Please note the following conditions:

The term of this Agreement is one year from purchase date.

In consideration for payment, you (The Licensee) are hereby granted a nonexclusive, worldwide, non-transferable, non-sub-licensable license during the term of this Agreement for digital use rights (web posting, email, digital presentations, branded social media and similar) and print reproduction use rights (letterhead, sales materials, reports, white papers, brochures, posters and signage and similar) of the Newsweek Logo (The Logo) pictured in this agreement.

The Licensee acknowledges and agrees that The Logo and all rights, title and interest herein are and shall remain the exclusive property of Newsweek.

The Licensee may not attribute any statement of fact to Newsweek beyond your placement on the list in your respective industry. You alone are responsible for the admissibility of the commercial use of The Logo under competition law; in this respect, Newsweek and Statista give no guarantee and assume no liability. Licensee shall not distort, misrepresent, alter the meaning of or otherwise edit The Logo. Newsweek may terminate this Agreement upon 30 days’ written notice if Licensee materially breaches any of the terms of this Agreement; provided, however, that this Agreement will not terminate if the breaching party has substantially cured the breach to the reasonable satisfaction of Newsweek within 30 days of a notice pursuant to this section.

Upon termination or expiration of this Agreement, Licensee’s right to use The Logo shall immediately terminate and all rights granted to Licensee hereunder with respect to The Logo shall automatically revert to Newsweek without further notice.

This Agreement contains the full and complete understanding of the parties with respect to the subject matter hereof and supersedes all prior representations and understanding, whether oral or written. This Agreement shall be construed and the rights and obligations of the parties shall be governed by the laws of the State of New York, without reference to its conflict of law principles.

All amounts described shall be in United States dollars and are net of all sales, use property and related taxes and customs duties.